CAVALIERE, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 394
EU - Europa 284
AS - Asia 191
SA - Sud America 4
Totale 873
Nazione #
US - Stati Uniti d'America 390
CN - Cina 127
IT - Italia 57
IE - Irlanda 54
SG - Singapore 49
SE - Svezia 44
FR - Francia 34
RU - Federazione Russa 31
DE - Germania 19
FI - Finlandia 15
GB - Regno Unito 12
BE - Belgio 7
CA - Canada 4
UA - Ucraina 4
IN - India 3
AM - Armenia 2
AT - Austria 2
CL - Cile 2
JP - Giappone 2
AL - Albania 1
BG - Bulgaria 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
ID - Indonesia 1
IR - Iran 1
KG - Kirghizistan 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
MY - Malesia 1
NL - Olanda 1
PE - Perù 1
SA - Arabia Saudita 1
VN - Vietnam 1
Totale 873
Città #
Chandler 113
Ashburn 57
Dublin 51
Singapore 42
Verona 22
Ann Arbor 18
Beijing 18
Jacksonville 17
Jinan 16
Helsinki 15
Lawrence 13
Princeton 13
Sindelfingen 12
Southend 11
Taiyuan 10
Wilmington 10
New York 9
Brussels 7
Tianjin 7
Washington 6
Haikou 5
Redmond 5
Zhengzhou 5
Changsha 4
Milan 4
Shenyang 4
Dongguan 3
Fuzhou 3
Guangzhou 3
Hebei 3
Seattle 3
Taizhou 3
Toronto 3
Bari 2
Dallas 2
Dearborn 2
Des Moines 2
Fairfield 2
Lanzhou 2
Los Angeles 2
Ningbo 2
Pieve Emanuele 2
Redwood City 2
Tokyo 2
Varese 2
Xiangfen 2
Yerevan 2
Alfonsine 1
Bishkek 1
Bologna 1
Brno 1
Clearwater 1
Falkenstein 1
Hangzhou 1
Houston 1
Jakarta 1
Jiaxing 1
Kashan 1
Kent 1
Landshut 1
Lima 1
London 1
Lutzingen 1
Mantova 1
Minsk 1
Moscow 1
Nanchang 1
Nocera Inferiore 1
Oklahoma City 1
Paris 1
Quito 1
Riyadh 1
Sacramento 1
San Diego 1
Santa Clara 1
Santiago 1
Seoul 1
Shantou 1
Sofia 1
Stockholm 1
Tirana 1
Vienna 1
Vientiane 1
Totale 579
Nome #
Pancreatic Cancer and Obesity: Molecular Mechanisms of Cell Transformation and Chemoresistance 104
A phase II study of liposomal irinotecan with 5-fluorouracil, leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trial 92
Organisational challenges, volumes of oncological activity and patients' perception during the severe acute respiratory syndrome coronavirus 2 epidemic 89
Plasma Interleukin-8 is a biomarker for TAK1 activation and predicts resistance to nanoliposomal irinotecan in patients with gemcitabine-refractory pancreatic cancer 81
Role of next-generation genomic sequencing in targeted agents repositioning for pancreaticoduodenal cancer patients 74
Novel Biomarkers for Prediction of Response to Preoperative Systemic Therapies in Gastric Cancer 73
A phase II trial of the FGFR inhibitor pemigatinib in patients with metastatic esophageal-gastric junction/gastric cancer trastuzumab resistant: the FiGhTeR trial 71
Multicenter Retrospective Analysis of Second-Line Therapy after Gemcitabine Plus Nab-Paclitaxel in Advanced Pancreatic Cancer Patients 60
Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort 59
KRAS wild-type pancreatic ductal adenocarcinoma: molecular pathology and therapeutic opportunities 58
Targeting KRAS: The Elephant in the Room of Epithelial Cancers 57
Evolving pancreatic cancer treatment: From diagnosis to healthcare management 39
Chemotherapy toxicity and activity in patients with pancreatic ductal adenocarcinoma and germline BRCA1-2 pathogenic variants (gBRCA1-2pv): a multicenter survey 33
Totale 890
Categoria #
all - tutte 4.018
article - articoli 4.018
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.036


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202033 0 0 0 0 3 6 7 0 2 1 2 12
2020/202184 6 6 3 11 8 25 1 10 0 2 8 4
2021/2022153 15 53 5 12 2 2 2 6 5 4 15 32
2022/2023317 15 39 22 48 19 87 0 29 47 5 5 1
2023/2024178 6 9 17 26 13 38 24 12 1 11 17 4
2024/2025125 12 21 18 58 16 0 0 0 0 0 0 0
Totale 890